Hydrogen fermentation technology scaled successfully, with U.S. regulatory approval and public listing achieved. Operating loss increased due to Factory 01 and listing costs, but cash position remains strong. Additional EUR 10 million funding secured for R&D and U.S. expansion.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.